The most successful molecular malaria vaccine developed so far, RTS,S, is based on a highly-conserved tandem repeat tetrapeptide (NANP) in the central repeat region of the CSP and a C-terminal region that contains T- and B-cell epitopes, although the central repeat region itself is highly variable in size among parasite isolates [102]. This evidence concerns the gene DNAJC5 and malaria.